Announcements Trials

Browse Landscape

Phase

Phase 1 7 Phase 2 4 Phase 1/2 3 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Neurofibroma, Plexiform 1

Interventions

Carboplatin 127 pembrolizumab 123 Cisplatin 112 Paclitaxel 102 Gemcitabine 83 Specimen Handling 80 Magnetic Resonance Spectroscopy 80 Docetaxel 69 Dexamethasone 59 Cyclophosphamide 59 Pemetrexed 54 Bevacizumab 54 Doxorubicin 52 durvalumab 51 Radiotherapy 49 Capecitabine 48 Radiation 47 Oxaliplatin 47 Fluorouracil 47 Rituximab 42 Leucovorin 42 Vincristine 41 Lenalidomide 39 Etoposide 38 atezolizumab 35 Nivolumab 35 Letrozole 35 Prednisone 31 Bortezomib 31 130-nm albumin-bound paclitaxel 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × AZD 6244 × 90 days × Clear all

NCT04924608 2026-03-23

KOMET

AstraZeneca

Phase 3 Active not recruiting

145 enrolled 17 charts 1 FDA

Neurofibromatosis 1, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon ⚡